Imeik Technology Development Co., Ltd. is a Chinese healthcare company with a low ESG risk rating score of 18.4. Specializing in research, development, manufacturing, and sales of biomedical materials, Imeik offers a range of products including Medical Cosmetic Platform, General Surgery Platform, and Biological Technology Platform.